News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Updates in the Management of Type 2 Diabetes Mellitus and Comorbid Dyslipidemia

EP. 1: Complications of Diabetes and Role of Insulin Resistance in Metabolic Syndrome

May 27th 2016

EP. 2: Comparison of Guidelines From ADA and AACE

May 27th 2016

EP. 3: How Does the Potential for Weight Gain Influence Choice of Therapies?

May 27th 2016

EP. 4: Variables Involved When Adding Medications to Treat Diabetes

May 27th 2016

EP. 5: The Influence of Lipid Guidelines on Real-World Practice Patterns

May 27th 2016

EP. 6: Alternatives to Add-On Therapy for T2D and Hyperlipidemia

May 27th 2016

EP. 7: WellCare's Initiatives To Improve Care for Members With Diabetes

May 27th 2016

EP. 8: Partnering With Providers to Prevent or Delay Complications Related to Diabetes

May 27th 2016

EP. 9: The Role of Managed Care in Identifying and Counseling Patients With Prediabetes

May 27th 2016

EP. 10: Addressing the Effect of Polypharmacy on Medication Adherence

May 27th 2016

EP. 11: Role of Clinical Practice Guidelines in the Management of Diabetes and Diabetes-Related Complications

May 27th 2016

EP. 12: Considerations Regarding Statin Therapy

May 27th 2016

EP. 13: Management of Hyperlipidemia in Patients With Liver Impairment or Renal Impairment

May 27th 2016

EP. 14: Advantages of Medications that Treat Multiple Conditions

May 27th 2016

EP. 15: Updates to Treatment Guidelines: Effects on Payers

May 27th 2016

EP. 16: Major Cost Drivers in T2D Management

May 27th 2016

EP. 17: Role of Early Intervention in Preventing Progression to T2D

May 27th 2016

EP. 18: How Drug Cost Influences Drug Selection

May 27th 2016

EP. 19: Impact of Cost on Patients' Access to Treatment

May 27th 2016

EP. 20: An Increased Emphasis on Individual Risk Factors and Goals

May 27th 2016

EP. 21: The Role of PCSK9 Inhibitors for Patients with Hyperlipidemia

May 27th 2016

EP. 22: Role of the Health Plan in Providing Support to Members With Diabetes

May 27th 2016

EP. 23: The Potential Role of PCSK9 Inhibitors for Patients With Hyperlipidemia

May 27th 2016

EP. 24: Complexities in Diabetes Care in 2017

May 27th 2016

EP. 25: Diabetes: Shifting Mindset for Cardiovascular Benefits

May 27th 2016

EP. 26: Practical Implications of the CANVAS Trial

May 27th 2016

EP. 27: Understanding the Safety Data in CANVAS

May 27th 2016

EP. 28: GLP-1 Receptor Agonists and Cardiovascular Benefit

May 27th 2016

EP. 29: Examining Cardiovascular Outcomes Trials

May 27th 2016

EP. 30: Raising the Bar on Cardiovascular Benefit

May 27th 2016

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

How Do GLP-1 Agonists Fit Into Stroke Care?

Exploring Identity, Appearance Experiences Among Patients With Alopecia

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text